During the past decade, Department of Pneumology CHU Charleroi conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Department of Pneumology CHU Charleroi" are "Non Small Cell Lung Carcinoma" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Immunotherapy" (1 trials), "Malignant Mesothelioma" (1 trials) and "Non-small Cell Lung Carcinoma" (1 trials). Many other conditions were trialed in "Department of Pneumology CHU Charleroi" in a lesser frequency.

Most popular intervention types in "Department of Pneumology CHU Charleroi" are "Drug" (4 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "(chemo)immunotherapy" (1 trials), "Adriamycin, cyclophosphamide, vindesine, valproic acid" (1 trials), "Concomitant Chemoradiotherapy - Radiotherapy 66 Gy, Cisplatin, and Docetaxel" (1 trials), "Concomitant Radiochemotherapy - Radiotherapy 66 Gy, Cisplatin, and Docetaxel" (1 trials) and "Lobectomy followed by concomitant mediastinal chemoradiotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Department of Pneumology CHU Charleroi" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Department of Pneumology CHU Charleroi". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Department of Pneumology CHU Charleroi, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Department of Pneumology CHU Charleroi, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".